These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25855674)

  • 1. Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant.
    Sohaib SM; Kyriacou A; Jones S; Manisty CH; Mayet J; Kanagaratnam P; Peters NS; Hughes AD; Whinnett ZI; Francis DP
    Europace; 2015 Dec; 17(12):1823-33. PubMed ID: 25855674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function.
    Jones S; Lumens J; Sohaib SMA; Finegold JA; Kanagaratnam P; Tanner M; Duncan E; Moore P; Leyva F; Frenneaux M; Mason M; Hughes AD; Francis DP; Whinnett ZI;
    Europace; 2017 Jul; 19(7):1178-1186. PubMed ID: 27411361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whether noninvasive optimization of AV and VV delays improves the response to cardiac resynchronization therapy.
    Urbanek B; Chudzik M; Klimczak A; Rosiak M; Lewek J; Wranicz JK
    Cardiol J; 2013; 20(4):411-7. PubMed ID: 23913460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization Therapy.
    Gold MR; Yu Y; Singh JP; Birgersdotter-Green U; Stein KM; Wold N; Meyer TE; Ellenbogen KA
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006055. PubMed ID: 30354310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy beyond nominal settings: who needs individual programming of the atrioventricular and interventricular delay?
    Bogaard MD; Meine M; Tuinenburg AE; Maskara B; Loh P; Doevendans PA
    Europace; 2012 Dec; 14(12):1746-53. PubMed ID: 22753868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial.
    Whinnett ZI; Sohaib SMA; Mason M; Duncan E; Tanner M; Lefroy D; Al-Obaidi M; Ellery S; Leyva-Leon F; Betts T; Dayer M; Foley P; Swinburn J; Thomas M; Khiani R; Wong T; Yousef Z; Rogers D; Kalra PR; Dhileepan V; March K; Howard J; Kyriacou A; Mayet J; Kanagaratnam P; Frenneaux M; Hughes AD; Francis DP
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1407-1416. PubMed ID: 29778861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed versus effective VV delay during CRT optimization: when what you see is not what you get.
    Bogaard MD; Meine M; Doevendans PA
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):403-9. PubMed ID: 23305237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).
    Chatterjee NA; Gold MR; Waggoner AD; Picard MH; Stein KM; Yu Y; Meyer TE; Wold N; Ellenbogen KA; Singh JP
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventricular delay interval optimization in cardiac resynchronization therapy guided by echocardiography versus guided by electrocardiographic QRS interval width.
    Bertini M; Ziacchi M; Biffi M; Martignani C; Saporito D; Valzania C; Diemberger I; Cervi E; Frisoni J; Sangiorgi D; Branzi A; Boriani G
    Am J Cardiol; 2008 Nov; 102(10):1373-7. PubMed ID: 18993158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practice.
    Whinnett ZI; Francis DP; Denis A; Willson K; Pascale P; van Geldorp I; De Guillebon M; Ploux S; Ellenbogen K; Haïssaguerre M; Ritter P; Bordachar P
    Int J Cardiol; 2013 Oct; 168(3):2228-37. PubMed ID: 23481908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally.
    Kyriacou A; Pabari PA; Mayet J; Peters NS; Davies DW; Lim PB; Lefroy D; Hughes AD; Kanagaratnam P; Francis DP; Whinnett ZI
    Int J Cardiol; 2014 Feb; 171(2):144-52. PubMed ID: 24332598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of VV optimization in relation to left ventricular lead position: an acute haemodynamic study.
    Khan FZ; Virdee MS; Read PA; Pugh PJ; Begley D; Fynn SP; Dutka DP
    Europace; 2011 Jun; 13(6):845-52. PubMed ID: 21427090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of the best pacing configuration and atrioventricular and interventricular delays optimization in cardiac resynchronization therapy.
    Socie P; Squara F; Semichon M; Thomas O; Khemache A; Riccini P; Squara P; Algalarrondo V; Moubarak G
    Pacing Clin Electrophysiol; 2018 Apr; 41(4):362-367. PubMed ID: 29405324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Effect of Different Optimizing Methods for Cardiac Resynchronization Therapy in Patients with Heart Failure: A Randomized and Controlled Pilot Study.
    Zhang Y; Xing Q; Zhang JH; Jiang WF; Qin M; Liu X
    Cardiology; 2019; 142(3):158-166. PubMed ID: 31189165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of AV delay and VV delay on left atrial pressure and waveform in ambulant heart failure patients: insights into CRT optimization.
    Chan WY; Blomqvist A; Melton IC; Norén K; Crozier IG; Benser ME; Eigler NL; Gutfinger D; Troughton RW
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):810-9. PubMed ID: 24502608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.
    Whinnett ZI; Sohaib SM; Jones S; Kyriacou A; March K; Coady E; Mayet J; Hughes AD; Frenneaux M; Francis DP;
    BMC Cardiovasc Disord; 2014 Apr; 14():42. PubMed ID: 24693953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Atrioventricular and Interventricular Optimization for Cardiac Resynchronization Therapy.
    Cobb DB; Gold MR
    Heart Fail Clin; 2017 Jan; 13(1):209-223. PubMed ID: 27886925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical Substrates Driving Response to Cardiac Resynchronization Therapy: A Combined Clinical-Computational Evaluation.
    Huntjens PR; Ploux S; Strik M; Walmsley J; Ritter P; Haissaguerre M; Prinzen FW; Delhaas T; Lumens J; Bordachar P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005647. PubMed ID: 29654125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical effects of programmer-guided atrioventricular and interventricular delay optimization: Intracardiac electrography versus echocardiography for cardiac resynchronization therapy in patients with heart failure.
    Wang D; Yu H; Yun T; Zang H; Yang G; Wang S; Wang Z; Jing Q; Han Y
    J Int Med Res; 2013 Feb; 41(1):115-22. PubMed ID: 23569136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.